logo-loader
viewSativa Group PLC

Sativa inks deal to distribute Goodbody Botanicals range to UK pharmacies

The deal with wholesaler Alliance Healthcare will provide access to over 10,000 high street retailer customers

Sativa Group PLC - Sativa inks deal to distribute Goodbody range to UK pharmacies

Sativa Group PLC (LON:SATI) has signed a deal to distribute its Goodbody Botanicals range of cannabidiol (CBD) products to pharmacies across the UK.

The deal with pharmaceutical, medical and healthcare product distributor Alliance Healthcare will provide access to over 10,000 high street retailer customers, Sativa said, adding that Alliance’s syndicated pharmacy salesforce, Skills in healthcare, had also been contracted to sell the Goodbody Botanicals range to 1,500 top performing independent pharmacy customers.

READ: Sativa raises £1.38mln to fund next stage of development

"The Alliance distribution agreement is a significant step in Sativa's Goodbody Botanicals CBD Wellness brand's objective to grow market share with high street pharmacies, grocers, and superstores", said Sativa chief executive Henry Lees-Buckley.

Sativa’s shares were trading at around 4p on the NEX Exchange in early deals on Friday.

Quick facts: Sativa Group PLC

Price: - -

NEX:SATI
Market: NEX
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Sativa Group PLC named herein, including the promotion by the Company of Sativa Group PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Sativa Investments PLC acquires UK-based PhytoVista Laboratories

Geremy Thomas, chief executive of Sativa Investments PLC (NEX:SATI), tells Proactive's Andrew Scott they've agreed to buy PhytoVista Laboratories, a UK-based lab that tests cannabis oils and hemp products, for £435,000. The British medicinal cannabis investment vehicle will pay £235,000...

on 4/7/18

2 min read